Showing results (81-90 of 96) with videos related to
Sort By:
Pageof 10
The Journal of Infectious Diseases|January 19, 2005
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in miceThomas C Greenough, Gregory J Babcock, Anjeanette Roberts, et al.Circulation Research|July 23, 2021
SARS-CoV-2 Initiates Programmed Cell Death in PlateletsMilka Koupenova, Heather A Corkrey, Olga Vitseva, et al.Antiviral Research|February 1, 2015
Heparin octasaccharide decoy liposomes inhibit replication of multiple virusesGabriel L Hendricks, Lourdes Velazquez, Serena Pham, et al.Journal of Virology|October 25, 2013
Evolution of the influenza A virus genome during development of oseltamivir resistance in vitroNicholas Renzette, Daniel R Caffrey, Konstantin B Zeldovich, et al.Molecular Biology and Evolution|February 26, 2015
Positive Selection Drives Preferred Segment Combinations during Influenza Virus ReassortmentKonstantin B Zeldovich, Ping Liu, Nicholas Renzette, et al.The Journal of Infectious Diseases|September 9, 2011
LPLUNC1 modulates innate immune responses to Vibrio choleraeOk S Shin, Taher Uddin, Robert Citorik, et al.Plos Genetics|March 4, 2014
Influenza virus drug resistance: a time-sampled population genetics perspectiveMatthieu Foll, Yu-Ping Poh, Nicholas Renzette, et al.Journal of Virology|November 2, 2018
Mutations in Influenza A Virus Neuraminidase and Hemagglutinin Confer Resistance against a Broadly Neutralizing Hemagglutinin Stem AntibodyKristina L Prachanronarong, Aneth S Canale, Ping Liu, et al.Nature Communications|May 16, 2024
ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infectionLindsey E Bazzone, Junji Zhu, Michael King, et al.Plos Pathogens|September 7, 2012
Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzeesTrevor J Morin, Teresa J Broering, Brett A Leav, et al.Pageof 10